Momenta Pharmaceuticals Inc

General

Total Cases27

Active Cases1

Patents100

CourtsD. Delaware D. New Jersey D. Massachusetts

TypeOperating Company

Elite Ratings

DCT

momentapharma.com

momenta-pharmaceuticals

momenta-pharmaceuticals

Ratings

Experience

Grade

Trend

DCT

L5

A

PTAB

L5

E

CAFC

L5

E

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
09/13/24	Momenta Pharmaceuticals Inc v. Mylan Pharmaceuticals Inc 2:22-CV-00750 ( W.D. PA )	CLAIM Construction Chart by MOMENTA PHARMACEUTICALS, INC.. (Attachments: # [1] Appendix Plaintiff's Table of Contents, # [2] Appendix Plaintiff's Ex. B, # [3] Appendix Plaintiff's Ex. C, # [4] Appendix Plaintiff's Ex. D, # [5] Appendix Plaintiff's Ex. E, # [6] Appendix Plaintiff's Ex. F, # [7] Appendix Plaintiff's Ex. G, # [8] Appendix Plaintiff's Ex. H, # [9] Appendix Plaintiff's Ex. I, # [10] Appendix Plaintiff's Ex. J, # [11] Appendix Plaintiff's Ex. K, # [12] Appendix Plaintiff's Ex. L, # [13] Appendix Defendant's Cover Page, # [14] Appendix Defendant's Ex. 1, # [15] Appendix Defendant's Ex. 2, # [16] Appendix Defendant's Ex. 3, # [17] Appendix Defendant's Ex. 4, # [18] Appendix Defendant's Ex. 5, # [19] Appendix Defendant's Ex. 6, # [20] Appendix Defendant's Ex. 7, # [21] Appendix Defendant's Ex. 8, # [22] Appendix Defendant's Ex. 9, # [23] Appendix Defendant's Ex. 10, # [24] Appendix Defendant's Ex. 11, # [25] Appendix Defendant's Ex. 12, # [26] Appendix Defendant's Ex. 13, # [27] Appendix Defendant's Ex. 14, # [28] Appendix Defendant's Ex. 15, # [29] Appendix Defendant's Ex. 16, # [30] Appendix Defendant's Ex. 17, # [31] Appendix Defendant's Ex. 18, # [32] Appendix Defendant's Ex. 19, # [33] Appendix Defendant's Ex. 20, # [34] Appendix Defendant's Ex. 21, # [35] Appendix Defendant's Ex. 22, # [36] Appendix Defendant's Ex. 23a, # [37] Appendix Defendant's Ex. 23b, # [38] Appendix Defendant's Ex. 24, # [39] Appendix Defendant's Ex. 25, # [40] Appendix Defendant's Ex. 26, # [41] Appendix Defendant's Ex. 27, # [42] Appendix Defendant's Ex. 28, # [43] Appendix Defendant's Ex. 29, # [44] Appendix Defendant's Ex. 30, # [45] Appendix Defendant's Ex. 31, # [46] Appendix Defendant's Ex. 32, # [47] Appendix Defendant's Ex. 33, # [48] Appendix Defendant's Ex. 34, # [49] Appendix Defendant's Ex. 35, # [50] Appendix Defendant's Ex. 36, # [51] Appendix Defendant's Ex. 37) (Flynn, Edward) (Entered: 09/13/2024) CLAIM Construction Chart by MOMENTA PHARMACEUTICALS, INC.. (Attachments: # [1] Appendix Plaintiff's Table of Contents, # [2] Appendix Plaintiff's Ex. B, # [3] Appendix Plaintiff's Ex. C, # [4] Appendix Plaintiff's Ex. D, # [5] Appendix Plaintiff's Ex. E, # [6] Appendix Plaintiff's Ex. F, # [7] Appendix Plaintiff's Ex. G, # [8] Appendix Plaintiff's Ex. H, # [9] Appendix Plaintiff's Ex. I, # [10] Appendix Plaintiff's Ex. J, # [11] Appendix Plaintiff's Ex. K, # [12] Appendix Plaintiff's Ex. L, # [13] Appendix Defendant's Cover Page, # [14] Appendix Defendant's Ex. 1, # [15] Appendix Defendant's Ex. 2, # [16] Appendix Defendant's Ex. 3, # [17] Appendix Defendant's Ex. 4, # [18] Appendix Defendant's Ex. 5, # [19] Appendix Defendant's Ex. 6, # [20] Appendix Defendant's Ex. 7, # [21] Appendix Defendant's Ex. 8, # [22] Appendix Defendant's Ex. 9, # [23] Appendix Defendant's Ex. 10, # [24] Appendix Defendant's Ex. 11, # [25] Appendix Defendant's Ex. 12, # [26] Appendix Defendant's Ex. 13, # [27] Appendix Defendant's Ex. 14, # [28] Appendix Defendant's Ex. 15, # [29] Appendix Defendant's Ex. 16, # [30] Appendix Defendant's Ex. 17, # [31] Appendix Defendant's Ex. 18, # [32] Appendix Defendant's Ex. 19, # [33] Appendix Defendant's Ex. 20, # [34] Appendix Defendant's Ex. 21, # [35] Appendix Defendant's Ex. 22, # [36] Appendix Defendant's Ex. 23a, # [37] Appendix Defendant's Ex. 23b, # [38] Appendix Defendant's Ex. 24, # [39] Appendix Defendant's Ex. 25, # [40] Appendix Defendant's Ex. 26, # [41] Appendix Defendant's Ex. 27, # [42] Appendix Defendant's Ex. 28, # [43] Appendix Defendant's Ex. 29, # [44] Appendix Defendant's Ex. 30, # [45] Appendix Defendant's Ex. 31, # [46] Appendix Defendant's Ex. 32, # [47] Appendix Defendant's Ex. 33, # [48] Appendix Defendant's Ex. 34, # [49] Appendix Defendant's Ex. 35, # [50] Appendix Defendant's Ex. 36, # [51] Appendix Defendant's Ex. 37) (Flynn, Edward) (Entered: 09/13/2024)
09/12/24	Momenta Pharmaceuticals Inc v. Mylan Pharmaceuticals Inc 2:22-CV-00750 ( W.D. PA )	ORDER granting [138] view138 Joint MOTION to Extend Time to to file their Joint Disputed Claim Terms Chart and Prehearing Statement. The parties may file their Joint Disputed Claim Terms Chart and PrehearingStatement by September 13, 2024. Signed by Judge Robert J. Colville on 9/12/24. Text-only entry; no PDF document will issue. This text-only entry constitutes the Order of the Court or Notice on the matter. (cjo) (Entered: 09/12/2024) ORDER granting [138] view138 Joint MOTION to Extend Time to to file their Joint Disputed Claim Terms Chart and Prehearing Statement. The parties may file their Joint Disputed Claim Terms Chart and PrehearingStatement by September 13, 2024. Signed by Judge Robert J. Colville on 9/12/24. Text-only entry; no PDF document will issue. This text-only entry constitutes the Order of the Court or Notice on the matter. (cjo) (Entered: 09/12/2024)
09/11/24	Momenta Pharmaceuticals Inc v. Mylan Pharmaceuticals Inc 2:22-CV-00750 ( W.D. PA )	Joint MOTION to Extend Time to to file their Joint Disputed Claim Terms Chart and Prehearing Statement by GLAND PHARMA, LTD., MYLAN PHARMACEUTICALS, INC., MYLAN TEORANTA, MYLAN, INC., NATCO PHARMA, LTD., VIATRIS, INC.. (Attachments: # 1 Proposed Order Proposed Order) (Pietragallo, William) (Entered: 09/11/2024)
09/03/24	Momenta Pharmaceuticals Inc v. Mylan Pharmaceuticals Inc 2:22-CV-00750 ( W.D. PA )	ORDER granting 135 Joint MOTION to Extend Time to Certain Discovery Deadlines by MOMENTA PHARMACEUTICALS, INC. Signed by Judge Robert J. Colville on 9/3/24. (cjo) (Entered: 09/03/2024)
09/03/24	Momenta Pharmaceuticals Inc v. Mylan Pharmaceuticals Inc 2:22-CV-00750 ( W.D. PA )	ORDER re 134 STIPULATION Regarding Deposition Limits by MOMENTA PHARMACEUTICALS, INC. Signed by Judge Robert J. Colville on 9/3/24. (cjo) (Entered: 09/03/2024)
08/29/24	Momenta Pharmaceuticals Inc v. Mylan Pharmaceuticals Inc 2:22-CV-00750 ( W.D. PA )	Joint MOTION to Extend Time to Certain Discovery Deadlines by MOMENTA PHARMACEUTICALS, INC.. (Attachments: # 1 Proposed Order) (Flynn, Edward) (Entered: 08/29/2024)
08/29/24	Momenta Pharmaceuticals Inc v. Mylan Pharmaceuticals Inc 2:22-CV-00750 ( W.D. PA )	STIPULATION Regarding Deposition Limits by MOMENTA PHARMACEUTICALS, INC.. (Flynn, Edward) (Entered: 08/29/2024)
08/14/24	Momenta Pharmaceuticals Inc v. Mylan Pharmaceuticals Inc 2:22-CV-00750 ( W.D. PA )	ORDER granting 130 Motion to Appear Pro Hac Vice as to Shannon Bloodsworth. Signed by Judge Robert J. Colville on 8/14/24. Text-only entry; no PDF document will issue. This text-only entry constitutes the Order of the Court or Notice on the matter. (cjo) (Entered: 08/14/2024)
08/14/24	Momenta Pharmaceuticals Inc v. Mylan Pharmaceuticals Inc 2:22-CV-00750 ( W.D. PA )	Proposed Order re 130 Motion to Appear Pro Hac Vice, by GLAND PHARMA, LTD., MYLAN PHARMACEUTICALS, INC., MYLAN TEORANTA, MYLAN, INC., NATCO PHARMA, LTD., VIATRIS, INC.. (Bloodworth, Shannon) (Entered: 08/14/2024)
08/14/24	Momenta Pharmaceuticals Inc v. Mylan Pharmaceuticals Inc 2:22-CV-00750 ( W.D. PA )	AFFIDAVIT re 130 Amended MOTION for attorney Shannon M. Bloodworth to Appear Pro Hac Vice, (Filing fee $70, Receipt # APAWDC-8406878) by GLAND PHARMA, LTD., MYLAN PHARMACEUTICALS, INC., MYLAN TEORANTA, MYLAN, INC., NATCO PHARMA, LTD., VIATRIS, INC. Affiant: Shannon M. Bloodworth. (Bloodworth, Shannon) (Entered: 08/14/2024)